Author

Claudia Arajol 1

1 Bellvitge University Hospital,Barcelona,Spain

CAN A PATIENT RATE THE ACTIVITY OF THEIR CROHN´S DISEASE THROUGH A MOBILE APP? THE MEDICROHN STUDY. 

Ana Echarri Piudo, Isabel Vera Mendoza, Jordi Guardiola Capon, Virginia Ollero, Beatriz Castro, Francisco Gallego, Mariam Aguas, Maria Chaparro Sanchez, D Ceballos, Claudia Arajol, Pilar Robledo Andrés, Sabino Riestra, Ignacio Marín-Jiménez, Pilar Nos Mateu, S García-López

INCIDENCE OF POST-INFECTIOUS IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA AFTER A NOSOCOMIAL NOROVIRUS GASTROENTERITIS OUTBREAK

Katja Serra, Gerard Surís, Claudia Arajol, Judit Orobitg, Blau Camps Aler, Pau Gilabert, Gemma Ibáñez-Sanz, A. Ruiz-Cerulla, Lorena Rodríguez-Alonso, Francisco Rodriguez-Moranta, Jordi Guardiola

INFLIXIMAB POPULATION PHARMACOKINETIC MODELLING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: ESTIMATION OF INDIVIDUAL PHARMACOKINETIC PARAMETERS AND TROUGH LEVELS PREDICTION

Lorena Rodríguez-Alonso, Eugenia Santacana, Núria Padullés, Helena Colom, Ariadna Padullés, Claudia Arajol, Sara Cobo, Alexandra Ruiz, Francisco Rodriguez, Jordi Bas, Joan Climent, Francisco Morandeira, Jordi Guardiola Capon

RESCUE THERAPY WITH ANTI-TNF AGENTS FOR ESTABLISHED POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A MULTICENTRE, RETROSPECTIVE, NATIONWIDE STUDY

Eugeni Domenech Morral, Fiorella Cañete, Miriam Mañosa, Ramiro Cruz Gonzalez Sueyro, Sabino Riestra Menéndez, Manuel Barreiro de Acosta, Pilar Nos, Eva Iglesias Flores, Ana Gutierrez Casbas, Raquel Ríos, Luis Bujanda Fernández de Piérola, Carlos Gonzalez Muñoza, Albert Villoria, María José Casanova González, Antonio García He

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero Gismero, Maria Vera, Sabino Riestra Menéndez, V García-Sánchez, Luisa de Castro, A Martin-Cardona, Xavier Aldeguer, M Mínguez, Manuel Barreiro de-Acosta, Montserrat Rivero, F Muñoz, Montserrat Andreu, A Bargallo, E García-Planella, J. L. Pé

RELATIONSHIP BETWEEN RIFAXIMIN THERAPY AND SEHCAT TEST IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME OR FUNCTIONAL DIARRHEA.

Alexandra Ruiz Cerulla, Sandra Maisterra, Claudia Arajol, Pau Gilabert, Katja Serra, Oriol Puig, Paula Notta, Francisco Rodriguez-Moranta, Lorena Rodríguez-Alonso, Elena Sanchez-Pastor, Jordi Guardiola Capon

Item 1 - 6 / 6
1